1-4 of 4
Gail J. Roboz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid Leukemia

Daniel A. Pollyea, John Barrett, Courtney D. DiNardo, Laura C. Michaelis, Gail J. Roboz, Robert Q. Le, Kelly J. Norsworthy, R. Angelo de Claro, Marc R. Theoret, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (5): 816–820.
https://doi.org/10.1158/1078-0432.CCR-21-2124
Published: 01 March 2022
View article titled, Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid Leukemia
Open the PDF for Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid Leukemia in another window
Journal Articles

Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia

Anthony M. Hunter, Hannah Newman, Amy E. Dezern, David P. Steensma, Sandrine Niyongere, Gail J. Roboz, Qianxing Mo, Onyee Chan, Aaron Gerds, David A. Sallman, William Dominguez-Viqueira, Christopher Letson, Maria E. Balasis, Markus Ball, Traci Kruer, Hailing Zhang, Jeffrey E. Lancet, Alan F. List, Mikkael A. Sekeres, Rami S. Komrokji, Eric Padron
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (22): 6095–6105.
https://doi.org/10.1158/1078-0432.CCR-21-0935
Published: 15 November 2021
View article titled, Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia
Open the PDF for Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia in another window
Includes: Supplementary data
Journal Articles

A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)

Eric Padron, Amy Dezern, Marcio Andrade-Campos, Kris Vaddi, Peggy Scherle, Qing Zhang, Yan Ma, Maria E. Balasis, Sara Tinsley, Hanadi Ramadan, Cassandra Zimmerman, David P. Steensma, Gail J. Roboz, Jeffrey E. Lancet, Alan F. List, Mikkael A. Sekeres, Rami S. Komrokji
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (15): 3746–3754.
https://doi.org/10.1158/1078-0432.CCR-15-2781
Published: 31 July 2016
View article titled, A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)
Open the PDF for A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML) in another window
Includes: Supplementary data
Journal Articles

Phase I Study of Bryostatin 1 and Fludarabine in Patients with Chronic Lymphocytic Leukemia and Indolent (Non-Hodgkin's) Lymphoma

John D. Roberts, Mitchell R. Smith, Eric J. Feldman, Louise Cragg, Michael M. Millenson, Gail J. Roboz, Connie Honeycutt, Rose Thune, Kristin Padavic-Shaller, W. Hans Carter, Viswanathan Ramakrishnan, Anthony J. Murgo, Steven Grant
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5809–5816.
https://doi.org/10.1158/1078-0432.CCR-05-2730
Published: 04 October 2006
View article titled, Phase I Study of Bryostatin 1 and Fludarabine in Patients with Chronic Lymphocytic Leukemia and Indolent (Non-Hodgkin's) Lymphoma
Open the PDF for Phase I Study of Bryostatin 1 and Fludarabine in Patients with Chronic Lymphocytic Leukemia and Indolent (Non-Hodgkin's) Lymphoma in another window